Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,934 | -10,331 | -90,973 | -78,434 | -67,627 |
| Depreciation Amortization | 487 | 243 | 936 | 569 | 438 |
| Accounts payable and accrued liabilities | -2,356 | -2,458 | 33,993 | 38,127 | 35,168 |
| Other Working Capital | -2,426 | -2,859 | 38,203 | 41,153 | 41,100 |
| Other Operating Activity | 10,496 | 6,527 | -14,411 | -23,919 | -25,362 |
| Operating Cash Flow | $-12,733 | $-8,878 | $-32,252 | $-22,504 | $-16,283 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21 | N/A | -581 | -80 | N/A |
| Investing Cash Flow | $-21 | $N/A | $-581 | $-80 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 90 | 90 | 90 |
| Other Financing Activity | -67 | -51 | -329 | 0 | 0 |
| Financing Cash Flow | $-67 | $-51 | $-239 | $90 | $90 |
| Beginning Cash Position | 95,502 | 95,502 | 128,574 | 128,574 | 128,574 |
| End Cash Position | 82,681 | 86,573 | 95,502 | 106,080 | 112,381 |
| Net Cash Flow | $-12,821 | $-8,929 | $-33,072 | $-22,494 | $-16,193 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,733 | -8,878 | -32,252 | -22,504 | -16,283 |
| Capital Expenditure | -21 | N/A | -581 | -80 | N/A |
| Free Cash Flow | -12,754 | -8,878 | -32,833 | -22,584 | -16,283 |